Johnson & Johnson (JNJ) has shined in the healthcare space, rallying 5% this week and 30% in 2025. An upgrade from Wells Fargo added momentum to the stock rally on Friday. Rick Ducat dives into the price action behind Johnson & Johnson by comparing the stock to peers in pharmaceuticals and the general health care sector. He analyzes the options front gauge and expected volatility on both sides of the trade.